Post job

Especialidades Dollder main competitors are Takeda Pharmaceuticals U.S.A., Inc., Daiichi Sankyo, and Endo Pharmaceuticals Inc.

Competitor Summary. See how Especialidades Dollder compares to its main competitors:

  • Employees at Takeda Pharmaceuticals U.S.A., Inc. earn more than most of the competitors, with an average yearly salary of $85,837.
Work at Especialidades Dollder?
Share your experience

Especialidades Dollder vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
1990
4.2
--$53.0M350
1928
4.3
Smyrna, GA3$5.7B7,600
Matrix Distributors
-
3.7
East Brunswick, NJ1--
1998
4.7
Deerfield, IL14$12.1B30,481
-
3.7
Cincinnati, OH1-600
2005
4.8
Parsippany-Troy Hills, NJ2$9.0B15,348
1980
4.9
Parsippany-Troy Hills, NJ2$2.4B6,500
1995
4.0
Newark, CA2$342.7M494
2015
4.3
Englewood, CO1$27.6M100
1987
4.4
Parsippany-Troy Hills, NJ1$22.0M350
2002
3.1
Ridgeland, MS1$4.3M25
1997
4.7
Malvern, PA3$2.6B385
1985
4.3
Fairfield, NJ1$145.0M300
-
3.9
Sanford, FL1$7.5M46

Rate Especialidades Dollder's competitiveness in the market.

Zippia waving zebra

Especialidades Dollder salaries vs competitors

Among Especialidades Dollder competitors, employees at Takeda Pharmaceuticals U.S.A., Inc. earn the most with an average yearly salary of $85,837.

Compare Especialidades Dollder salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Especialidades Dollder
$80,124$38.52-
UCB
$67,621$32.51-
Matrix Distributors
$65,625$31.55-
Takeda Pharmaceuticals U.S.A., Inc.
$85,837$41.27-
Merrell Pharmaceuticals Inc
$61,421$29.53-
Daiichi Sankyo
$82,543$39.68-

Compare Especialidades Dollder job title salaries vs competitors

CompanyHighest salaryHourly salary
Especialidades Dollder
$62,795$30.19
Takeda Pharmaceuticals U.S.A., Inc.
$70,393$33.84
Endo Pharmaceuticals Inc
$68,011$32.70
Daiichi Sankyo
$67,880$32.63
PDI
$67,507$32.46
Hill Dermaceuticals
$65,850$31.66
Depomed
$65,391$31.44
UCB
$64,952$31.23
Wraser Pharmaceutical
$64,836$31.17
Merrell Pharmaceuticals Inc
$64,268$30.90
Brad Pharm
$63,941$30.74
Ferring Pharmaceuticals
$63,632$30.59
Matrix Distributors
$62,641$30.12
Aytu BioPharma
$62,469$30.03

Do you work at Especialidades Dollder?

Is Especialidades Dollder able to compete effectively with similar companies?

Especialidades Dollder jobs

Especialidades Dollder demographics vs competitors

Compare gender at Especialidades Dollder vs competitors

Job titleMaleFemale
UCB47%53%
Ferring Pharmaceuticals48%52%
Takeda Pharmaceuticals U.S.A., Inc.49%51%
Daiichi Sankyo51%49%
Endo Pharmaceuticals Inc52%48%
Especialidades Dollder--

Compare race at Especialidades Dollder vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
60%15%11%10%4%
9.5
60%13%12%11%4%
9.8
62%13%12%10%4%
9.8
61%13%11%12%4%
9.7
59%13%15%10%4%
9.8
64%13%13%7%3%
9.8

Especialidades Dollder and similar companies CEOs

CEOBio
Dan Peisert
Depomed

Ken Keller
Daiichi Sankyo

Sudheendra Kulkarni
Ferring Pharmaceuticals

Country Manager enabling teams to deliver the present and charter the future aspirations, setting vision, strategising to capitalise on emerging opportunities in India and South Asian regions. P&L leader with multiple TA domain expertise, and across geographies in leading MNC,Indian companies with cultural diversity. Expertise in healthcare Sales& Marketing, Strategy, Business operations, new business venture management, strategic planning, managing acquisition, strategic alliance management, and International Business ( Includes Indian subcontinent of Srilanka, Bangladesh, Pakistan, Maldives etc), and exposure across AP markets. Expertise in leading profitable growth at South west Asia cluster country level. specialty,chronic and mass base business units across leading MNC & Indian companies.Setting up of Key Account Management and international business.

Daniel Glassman
Brad Pharm

Jean-Christophe Tellier
UCB

Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, President of the Board of the European Federation of Pharmaceutical Associations (EFPIA), a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America) and a member of the Board of WELBIO (Walloon Institute for Life Lead Sciences). Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 30-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world. His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years. For Jean-Christophe “engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”. As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents

Jimmy Frangis
PDI

Joshua R. Disbrow
Aytu BioPharma

Especialidades Dollder competitors FAQs

Search for jobs